Marc Lipsitch1, David L Swerdlow1, Lyn Finelli1. 1. From the Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (M.L.); Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA (D.L.S.); and the Center for Observational and Real-World Evidence, Merck, Kenilworth, NJ (L.F.).
Authors: G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta Journal: Pharmacol Ther Date: 2020-05-19 Impact factor: 12.310
Authors: Sheraz R Markar; Guy Martin; Marta Penna; Seema Yalamanchili; Jasmine Winter Beatty; Jonathan Clarke; Simon Erridge; Viknesh Sounderajah; Max Denning; Alasdair Scott; Sanjay Purkayastha; James Kinross Journal: Ann Surg Date: 2020-05-01 Impact factor: 12.969
Authors: Benjamin Rader; Christina M Astley; Karla Therese L Sy; Kara Sewalk; Yulin Hswen; John S Brownstein; Moritz U G Kraemer Journal: J Travel Med Date: 2020-11-09 Impact factor: 8.490
Authors: Joshua S Weitz; Stephen J Beckett; Ashley R Coenen; David Demory; Marian Dominguez-Mirazo; Jonathan Dushoff; Chung-Yin Leung; Guanlin Li; Andreea Măgălie; Sang Woo Park; Rogelio Rodriguez-Gonzalez; Shashwat Shivam; Conan Y Zhao Journal: Nat Med Date: 2020-05-07 Impact factor: 53.440